Sen. Collins, Colleagues Introduce Bill to Streamline FDA Process to Develop New Medications, Medical Products
May 07, 2022
May 07, 2022
WASHINGTON, May 7 -- Sen. Susan M. Collins, R-Maine, issued the following news release:
U.S. Senators Susan Collins (R-ME), Mark Kelly (D-AZ), and Kyrsten Sinema (D-AZ) introduced legislation to streamline the federal government's process to develop drugs and other medical products by continuing the Food and Drug Administration's public-private partnerships with universities and non-profit organizations. The bipartisan bill will also reauthorize the Critical Path Public-Pr . . .
U.S. Senators Susan Collins (R-ME), Mark Kelly (D-AZ), and Kyrsten Sinema (D-AZ) introduced legislation to streamline the federal government's process to develop drugs and other medical products by continuing the Food and Drug Administration's public-private partnerships with universities and non-profit organizations. The bipartisan bill will also reauthorize the Critical Path Public-Pr . . .